Viewing Study NCT04234659


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-01-01 @ 9:34 AM
Study NCT ID: NCT04234659
Status: UNKNOWN
Last Update Posted: 2021-12-13
First Post: 2019-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PPCM Observational Study (Peripartum Cardiomyopathy)
Sponsor: Medical College of Wisconsin
Organization:

Study Overview

Official Title: Observational Study for Outcomes for Participants With Cardiogenic Shock and Peripartum Cardiomyopathy
Status: UNKNOWN
Status Verified Date: 2021-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
Detailed Description: This single-site, virtual, longitudinal, observational study will investigate two cohorts (study groups) by enrolling a total of ten participants, five in each cohort. The two cohorts include individuals who received mechanical circulatory support (specifically the IMPELLA® device) compared to individuals who did not receive mechanical circulatory support for treatment of their PPCM complicated by cardiogenic shock index event.

The duration of enrollment for each participant is about 5 months. It is anticipated that the trial will be complete in 12 months. Participant engagement to the study will be self-initiated.

Under the guidance and support of Medical College of Wisconsin research coordinator, participants will directly access the study REDCapTM database for enrollment and follow-up data entry for this study. The research coordinator will obtain and abstract participant medical records documenting the event.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: